Akers biosciences, inc. (AKER)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Product Revenue

1,328

1,577

1,776

1,913

1,975

1,665

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

2,956

2,739

2,295

2,083

1,757

2,689

2,879

2,540

2,453

1,410

1,311

1,267

1,325

0

0

0

Product Revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product Revenue - Related party

-

-

-

-

-

-

-

-

-

-

-

-

24

0

0

0

0

-

-

0

-

1,630

1,798

1,798

1,565

1,719

0

0

0

License & Service Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

15

25

35

25

10

10

0

0

200

0

0

0

License Revenue - Related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

305

378

462

333

333

333

333

333

333

0

0

0

Total Revenues

-

-

-

-

-

-

-

-

-

-

-

-

2,890

2,960

2,776

2,332

2,343

2,115

3,093

3,377

3,763

4,427

3,551

3,443

3,166

3,577

0

0

0

Product Cost of Sales

1,025

1,098

1,212

1,403

1,486

1,538

2,610

2,457

2,444

2,406

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product Cost of Sales

-

-

-

-

-

-

-

-

-

-

-

-

-

1,083

919

860

924

950

1,012

996

797

1,175

1,318

1,250

1,741

1,913

0

0

0

Gross Income

303

478

564

509

488

127

-285

-13

545

948

1,826

1,850

1,748

1,877

1,857

1,472

1,418

1,164

2,080

2,380

2,966

3,251

2,233

2,192

1,424

1,664

0

0

0

Sales and Marketing Expenses - Related Party

-

-

-

-

-

-

-

-

-

-

164

247

186

153

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Sales and Marketing Expenses - Related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

195

329

430

539

428

0

0

0

Research and Development Expenses

0

-

410

513

-

1,063

1,190

1,320

1,351

1,260

1,185

1,142

1,174

1,188

1,336

1,408

1,464

1,406

1,233

1,097

968

916

937

987

1,012

1,006

0

0

0

Administrative Expenses

3,903

3,728

4,337

5,149

5,733

5,666

5,830

4,942

4,207

4,082

3,150

2,889

2,875

3,008

3,986

4,188

4,254

4,029

3,822

3,889

4,023

3,784

2,646

2,089

1,343

1,095

0

0

0

Administrative Expenses - Related Party

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales and Marketing Expenses

102

238

650

976

1,432

1,782

2,128

2,106

1,992

2,048

1,590

1,656

1,814

1,983

2,335

2,653

2,693

2,543

2,190

1,823

1,666

1,302

1,114

882

661

684

0

0

0

Regulatory and Compliance Expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and Development Expenses - Related Party

-

-

-

-

-

-

-

-

-

-

0

22

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation Settlement Expenses

-

141

1,005

0

0

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Reversal of Allowance for) Bad Debt Expenses- Related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Impairment of Non-Current Assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

Amortization of Non-Current Assets

38

40

72

105

138

171

171

171

171

171

171

171

171

171

171

192

214

236

258

258

258

258

258

258

258

258

0

0

0

Loss from Operations

-6,551

-3,946

-5,556

-7,815

-9,106

-10,060

-10,384

-8,437

-7,145

-6,613

-4,458

-2,979

-3,173

-3,328

-6,090

-8,736

-9,838

-9,682

-6,755

-5,552

-3,950

-3,204

-3,052

-2,454

-2,392

-1,810

0

0

0

Other (Income) Expenses
Impairment of Non-Current Assets

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of equity investment - Related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Foreign Currency Transaction Loss

-

5

6

5

8

6

9

13

11

-1

-11

-10

-9

3

8

6

10

7

3

2

-6

-2

1

0

2

-0

0

0

0

Other Income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-0

-0

-6

0

0

0

-

-

-

-

-

-

-

-

Other Income

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

0

91

0

-

0

0

-

Loss on Investments

29

-3

4

15

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain from demutualization of insurance carrier

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

4

4

4

91

0

0

0

Interest and Dividend Income

116

101

114

135

160

165

133

94

44

10

27

29

34

21

-9

-35

-80

-102

-131

-130

-112

-69

-27

-8

10

1

0

0

0

Total Other Income

-41

-57

829

817

799

788

648

688

731

752

14

23

20

25

-18

-45

-70

-100

-143

-143

-133

-76

-21

-2

209

283

0

0

0

Loss Before Income Taxes

-6,509

-3,888

-6,386

-8,633

-9,906

-10,849

-11,032

-9,126

-7,877

-7,366

-4,440

-2,952

-3,143

-3,303

-6,054

-8,691

-9,768

-9,581

-6,647

-5,444

-3,853

-3,127

-2,996

-2,416

-2,182

-1,526

0

0

0

Income Tax Benefit

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-269

-269

-269

-269

0

0

0

0

0

0

0

0

0

0

0

Preferred Stock Dividend

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

Net Loss

-6,509

-3,888

-6,386

-8,633

-9,906

-10,849

-11,032

-9,126

-7,877

-7,366

-4,440

-2,952

-3,143

-3,303

-5,784

-8,421

-9,499

-9,311

-6,647

-5,444

-3,869

-3,142

0

0

0

-

-

-

0

Other Comprehensive Income (Loss)
Net Loss Attributable to Common Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Net Unrealized Loss on Marketable Securities

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Unrealized Gain (Loss) on Marketable Securities

-226

43

25

33

20

-25

0

0

0

-

-

-

-2

6

-14

-2

-4

13

23

6

17

-20

-11

-3

-10

0

0

0

0

Total Other Comprehensive Income (Loss)

-226

43

25

33

20

-25

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive Loss

-6,736

-3,844

-6,361

-8,599

-9,885

-10,874

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Other Comprehensive Loss

-

-

-

-

-

-

-

-

-

-

2

0

-2

6

-14

-2

-4

13

23

6

17

-20

-11

-3

-10

0

0

0

0

Comprehensive Loss

-

-

-

-

-

-

-

-

-

-7,366

-4,438

-2,952

-3,146

-3,297

-5,798

-8,424

-9,503

-9,298

-6,624

-5,438

-3,851

-3,163

-3,023

-2,435

-2,193

-1,526

0

0

0

Basic income/(loss) per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.06

-

-

-

-0.45

-

-

-

-

-

-

-

-

-

-

Diluted income/(loss) per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.06

-

-

-

-0.45

-

-

-

-

-

-

-

-

-

-

Weighted average basic common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,434

-

-

-

5,144

-

-

-

-

-

-

-

-

-

-

Weighted average diluted common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,508

-

-

-

5,144

-

-

-

-

-

-

-

-

-

-

Basic and Diluted loss per common share

-1.59

-4.52

-0.07

-0.06

-1.70

-21.63

-0.26

-0.18

-0.21

-4.97

-1.04

-0.09

-0.19

-

-

-0.19

-0.28

-

-

-0.41

-0.26

-0.19

-0.23

-0.10

-0.14

-0.52

-0.30

-0.19

0.05

Weighted average basic and diluted common shares outstanding

2,226

-23,103

12,512

12,500

540

-30,444

11,779

11,656

8,956

-12,300

1,111

8,882

6,993

-

-

5,427

5,425

-

-

5,144

5,125

4,965

4,924

4,894

4,197

1,947

1,791

1,369

1,278